or Try an Advanced Search...

    Technical Analysis for WGS - GeneDx Holdings Corp.

    Grade Last Price % Change Price Change
    A 28.69 9.76% 2.55
    WGS closed up 9.76 percent on Monday, July 1, 2024, on approximately normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical WGS trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze Started Range Contraction 0.00%
    Fell Below 20 DMA Bearish 9.76%
    Volume Surge Other 9.76%
    Wide Bands Range Expansion 9.76%
    20 DMA Support Bullish 7.70%
    Pocket Pivot Bullish Swing Setup 7.70%
    Wide Bands Range Expansion 7.70%
    Outside Day Range Expansion 9.55%
    Older End-of-Day Signals for WGS ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 6 hours ago
    Rose Above Previous Day's High about 6 hours ago
    Rose Above 10 DMA about 6 hours ago
    Up 5% about 6 hours ago
    Up 3% about 6 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    WGS Chart by TradingView
    Basic chart:

    Profile

    GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics

    Is WGS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 Insiders Buying GeneDx Holdings Might Wish They Invested More, Stock Gains 12%
    Jun 10 GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
    Jun 6 Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buying
    Jun 6 GeneDx Holdings: Mapping A Path To Leadership In Pediatric Genetic Testing
    Jun 5 GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
    May 29 Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buying
    May 22 GeneDx to Participate in Upcoming Investor Conferences
    May 2 GeneDx Holdings Corp. (NASDAQ:WGS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
    May 1 GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2024 Earnings Call Transcript
    May 1 GeneDx Holdings First Quarter 2024 Earnings: Beats Expectations
    See more WGS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 29.11
    52 Week Low 1.16
    Average Volume 552,805
    200-Day Moving Average 8.91
    50-Day Moving Average 21.68
    20-Day Moving Average 26.68
    10-Day Moving Average 27.21
    Average True Range 1.99
    RSI (14) 64.91
    ADX 38.85
    +DI 25.75
    -DI 15.35
    Chandelier Exit (Long, 3 ATRs) 23.14
    Chandelier Exit (Short, 3 ATRs) 25.51
    Upper Bollinger Bands 30.02
    Lower Bollinger Band 23.34
    Percent B (%b) 0.8
    BandWidth 25.02
    MACD Line 1.67
    MACD Signal Line 1.99
    MACD Histogram -0.3224
    Fundamentals Value
    Market Cap 742.62 Million
    Num Shares 25.9 Million
    EPS -35.44
    Price-to-Earnings (P/E) Ratio -0.81
    Price-to-Sales 0.51
    Price-to-Book 0.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 33.53
    Resistance 3 (R3) 33.09 31.03 32.73
    Resistance 2 (R2) 31.03 29.80 31.25 32.46
    Resistance 1 (R1) 29.86 29.03 30.44 30.30 32.19
    Pivot Point 27.80 27.80 28.09 28.02 27.80
    Support 1 (S1) 26.63 26.57 27.22 27.08 25.19
    Support 2 (S2) 24.57 25.80 24.79 24.92
    Support 3 (S3) 23.40 24.57 24.65
    Support 4 (S4) 23.85